Antisense oligonucleotide modulation of STAT3 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorJames G. Karras
Life of this patent
Estimating the term…
Abstract
Compounds, compositions and methods are provided for inhibiting the expression of human STAT3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding STAT3. Methods of using these oligonucleotides for inhibition of STAT3 expression and for promotion of apoptosis are provided. Methods for treatment of diseases, particularly inflammatory diseases and cancers, associated with overexpression or constitutive activation of STAT3 or insufficient apoptosis are also provided.
Claims15
An antisense compound 20 to 30 nucleobases in length targeted to nucleobases 637-656 and 1669-1688 of human STAT3 (SEQ ID NO:
- 1), wherein said antisense compound inhibits the expression of human STAT3.
Dependencies are inferred from the claim text.